相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA A multicenter study
M. Saqqur et al.
NEUROLOGY (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Patients with Acute Stroke Treated with Intravenous tPA 3-6 Hours after Stroke Onset: Correlations between MR Angiography Findings and Perfusion- and Diffusion-weighted Imaging in the DEFUSE Study
Michael P. Marks et al.
RADIOLOGY (2008)
Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial
J. Montaner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat
Li Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion
Neil A. Turner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection
Xian Shuang Liu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat
L Zhang et al.
CIRCULATION (2005)
Protective effects of statin involving both eNOS and tPA in focal cerebral ischemia
M Asahi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Statins and stroke
M Endres
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model
L Zhang et al.
STROKE (2004)
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
S Kinlay et al.
CIRCULATION (2003)
Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats
JL Chen et al.
CIRCULATION RESEARCH (2003)
Prevention of stroke and dementia with statins: Effects beyond lipid lowering
CJ Vaughan
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus
MA van de Ree et al.
ATHEROSCLEROSIS (2003)
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke
M Castellanos et al.
STROKE (2003)
Thrombolytic treatment of clot embolism in rat - Comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator
F Niessen et al.
STROKE (2002)
Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease
KK Koh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
U Laufs et al.
BRAIN RESEARCH (2002)
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats
T Sumii et al.
STROKE (2002)
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion
ZG Zhang et al.
BRAIN RESEARCH (2001)
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke
PA Lapchak et al.
STROKE (2000)
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
U Laufs et al.
STROKE (2000)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)